Paxlovid is startlingly expensive. As with many drugs in the United States, its pricing deserves renewed scrutiny. Among a handful of approved anti-retrovirals, the drug is the go-to prescription medicine to treat mild-to-moderate COVID-19 in adults. It can reduce the likelihood of ending up in the hospital for people at elevated risk. For older people… Read More »
Racial residential segregation in the US is persistent and associated with racial health inequities. This month’s special guest is Dr. Kristen Brown, a senior research associate at Urban Institute. We discuss her recent publication Still Separate, Still Not Equal: An ecological examination of redlining and racial segregation with COVID-19 vaccination administration in Washington DC. We… Read More »
This post was originally published on KFF Health News. It is published with open permission by that site. Measles is on the rise in the United States. In the first quarter of this year, the number of cases was about 17 times what it was, on average, during the same period in each of the four… Read More »
The pandemic public health emergency declaration ends today in the United States. Here, I share a look back and what to expect going forward. One thing is clear: with this change in designation, the U.S. has revealed that its public health preparedness was always meant to be temporary. Where we started It was December 12,… Read More »
In March 2020, the Centers for Disease Control and Prevention (CDC) confirmed COVID-19 as a pandemic. More than 18 months later, the nation has yet to return to ‘normal’. Hope for normalcy increased with the rollout of COVID-19 vaccines in the months that followed. Reluctance and resistance to vaccination, however, have made it difficult to… Read More »